Image

LOWER: Lomitapide Observational Worldwide Evaluation Registry

Recruiting
years of age
Both
Phase N/A

Powered by AI

Overview

This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.

Description

To evaluate the occurrence of adverse events of special interest, long term effectiveness of lomitapide, and to evaluate whether prescribers of lomitapide are following screening and monitoring recommendations as specified in product labeling.

Eligibility

Inclusion Criteria:

  • Patients of all ages, including minors, who have initiated commercial treatment with lomitapide prior to or at time of registry enrolment.
  • Patients who have the ability to understand the requirements of the study and provide written informed consent to comply with the study data collection procedures or paediatric patients with the consent of a parent or legal guardian.
        Patients ≥7 years of age (or above the age determined by the IRB/EC and in accordance with
        the local regulations and requirements) must also provide written informed assent forms.
        Exclusion Criteria:
          -  Patients who are receiving lomitapide in clinical trials or through compassionate use,
             where patients are followed under a separate protocol.
          -  Patients receiving an investigational agent, defined as any drug or biologic agent
             other than lomitapide that has not received market authorization in the country of
             participation, at time of lomitapide initiation and continuing to receive an
             investigational agent at time of registry enrolment. These patients may be enrolled if
             receiving lomitapide when the investigational agent is discontinued..

Study details

Homozygous Familial Hypercholesterolemia

NCT02135705

Amryt Pharma

19 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.